BDI Pharma, LLC.
BDI reps are on-call for all your emergency and after-hours ordering. Call 1-800-948-9834 to place an order today.
  
BDI Pharma is a Verified-Accredited Wholesale Distributor  one of 34 active members of the HDMA, and a member of HISCI.   Always rest assured your product is being handled with the utmost care and professionalism.

How useful is their pedigree?
Click here to see.
Healthcare doesn't stop with humans. See how our level of expertise has reached the world of our special friends at www.4legPharma.com
Effective April 1, 2012 through June 30, 2012. Visit the Centers for Medicare & Medicaid Services for more information.


Monoclate-P®
Manufacturer: CSL Behring
Generic Name: Antihemophilic Factor VIII (Human) - Monoclonal
Indications:
  • Monoclate-P® is indicated for treatment of classical hemophilia (HemophiliaA).
  •  
    • Affected individuals frequently require therapy following minor accidents.
    •  
    • Surgery, when required in such individuals, must be preceded by temporary corrections of the clotting abnormality.
    •  
    • Surgical prophylaxis in severe AHF deficiency can be accomplished with as appropriately dosed pre-surgical IV bolus of Monoclate-P® followed by intermittent maintenance doses
    .

  • Monoclate-P® is not effective in controlling bleeding of patients with von Willebrand's disease.
How Supplied: Factor products are supplied in vials sizes of varying International Units (iu). Vial sizes (iu sizes) may change with each new lot of product manufactured. Vial sizes may range from approximately 200 - 1500 iu per vial.
 
Product Size NDC Numbers  PI MSDS
Monoclate-P® 250 unit vial 00053-7656-01 PI MSDS
Monoclate-P® 500 unit vial 00053-7656-02 PI MSDS
Monoclate-P® 1000 unit vial 00053-7643-01 PI MSDS
Monoclate-P® 1500 unit vial 00053-7644-01 PI MSDS
 
Clinical Data:  For any questions or for further information related to Monoclate-P®, Antihemophilic Factor VIII, clinical pharmacology, additional indications and usages, contraindications, warnings, precautions, adverse reactions, dosage, administration and/or storage of this product, please contact BDI Pharma or call  1-800-948-9834.